Nocturnal Penile Tumescence
Morning Erections (NPT), What They Indicate, and Their Diagnostic Use in ED
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- NPT/RigiScan testing is a recognized diagnostic; not a treatment
Reference only. Not medical advice.
What can go wrong
Low physiologic risk, this is an observation, not an intervention. The risk is over-interpretation: men buying testosterone or PDE5 inhibitors online based solely on reduced morning erections, bypassing evaluation that might reveal a vascular or psychological cause better addressed directly.
This is something to take to a clinician. The Atlas can tell you what is known about nocturnal penile tumescence in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Nocturnal penile tumescence (NPT) is the cluster of erections that occur during REM sleep, typically 3-5 per night, with the last often persisting into waking as the 'morning erection.' NPT is largely independent of conscious arousal, so its presence indicates that the vascular and neurological machinery of erection is intact. Historically, NPT testing (and the RigiScan monitor) was used to distinguish organic from psychogenic erectile dysfunction: preserved nocturnal erections with daytime ED point toward a psychogenic component, while loss of NPT suggests an organic (vascular, neurologic, or hormonal) cause. Loss of morning erections can therefore be an early, meaningful signal worth investigating.
Morning wood is a nightly stress-test of the erectile hardware.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
During REM sleep, a shift in autonomic balance (reduced sympathetic outflow and pro-erectile parasympathetic/nitrergic activity) triggers penile erections that do not depend on sexual stimulation. Because they bypass psychological arousal, they serve as a physiological probe: if the endothelium, cavernosal smooth muscle, nerves, and androgen milieu are healthy, NPT generally occurs. Testosterone modulates NPT, so reduced nocturnal erections can accompany hypogonadism as well as vascular or neurologic disease.
What loss of NPT does and doesn't prove
Absent morning erections raise the probability of an organic cause but are not by themselves diagnostic, poor or fragmented sleep, depression, and certain medications (notably SSRIs and some antihypertensives) also reduce NPT without primary erectile-tissue disease. Conversely, occasional morning erections do not rule out evolving vascular disease. NPT is a useful flag and a research-grade discriminator, not a stand-alone verdict.
What people get wrong
Often saidLosing morning wood always means you have low testosterone
ActuallyNot always. Vascular disease, neuropathy, depression, poor sleep, and SSRIs/antihypertensives can all reduce NPT. It warrants evaluation, not a self-diagnosis of low T or a self-started testosterone purchase.
Often saidIf you still get morning erections your ED is 'all in your head'
ActuallyPreserved NPT shifts probability toward a psychogenic or situational component but does not exclude early organic disease; it is one input among several.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Frequency
- ~3-5 erections/night, REM-linked
- Total tumescence
- ~1-3 hours per night in healthy young men
- Diagnostic tool
- RigiScan / NPT monitoring
- Classic logic
- Preserved NPT + daytime ED = likely psychogenic
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Nocturnal Penile Tumescence. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Karacan I et al.1970s
Pioneered NPT monitoring during sleep and established its link to REM and its use in classifying impotence
Bradley WE et al. (RigiScan development)1985
Introduced ambulatory rigidity monitoring, enabling home NPT testing to assess organic versus psychogenic ED
Bancroft J & Wu FC1983
Showed testosterone influences nocturnal erections, linking androgen status to NPT